RICHMOND, Va., Dec. 27, 2001 (PRIMEZONE) -- Senior executives from four Biotechnology companies will discuss their prospects and strategies at the January 12, 2002 Biotechnology Stocks Forum sponsored by Informed Investors at the Berkeley, CA Radisson Marina hotel. The event is open to the public and information and registration are available on the Internet at www.informedinvestors.com or by calling 804-327-7122.
Current and potential investors will get 'straight from the source' presentations from senior executives of biopharmaceutical companies including AEterna Laboratories (Nasdaq:AELA) (TSE:AEL), and Gene Logic Inc. (Nasdaq:GLGC). Executives will review their companies for approximately 25 minutes each with PowerPoint presentations. A 5-10 minute question and answer session with the investor audience follows each presentation. The forum will also be archived on the Internet at www.vcall.com and www.investorconference.com.
Other companies presenting at the forum include OraPharma, Inc. and VaxGen. Adding to the depth of the Forum will be keynote speaker Ronald Garren, a board certified internist. He is a graduate of Harvard Medical School and did a three-year postdoctoral fellowship in molecular biology at Stanford in Dr. Paul Berg's lab. His clinical expertise is in the field of oncology. He has a founder equity position in Rigel pharmacy, a private biotech company in southern San Francisco. Garren's experience and expertise enables him to present a valuable perspective to individuals interested in investing in biotech companies.
Quebec City-based AEterna Laboratories Inc. is a biopharmaceutical company and a leader in the field of angiogenesis inhibitors. The Company's efforts are mainly focused on developing new cancer therapies. AEterna recently announced that it has completed patient recruitment for its international Phase III clinical trial in renal cell carcinoma. Conducted by an international team of oncology experts, the study aims to determine whether AEterna's lead compound, Neovastat can increase survival time in patients who have failed to respond to standard immunotherapy treatments. Trial results are expected in early 2003.
Based in Gaithersburg, Maryland, Gene Logic, Inc. is a leading provider of biocontent and bioinformatics solutions related to gene activity in human disease and toxicity to optimize rapid, reliable and cost-effective pharmaceutical and biotechnology research and development. Through the systematic and industrialized application of genomics, the Company provides a growing portfolio of genomic information solutions based on its core database product, the GeneExpress(r) Suite. Gene Logic recently announced an expansion of its business relationship with Pfizer Inc. focused on Pfizer's adoption of additional GeneExpress(r) Suite information products and services for use in their drug development initiatives.
Informed Investors is the leading producer of online and offline industry-specific investment conferences for individual investors and a member of the World Investor Link family of companies serving self-reliant investors.
About World Investor Link: Since 1992, World Investor Link (www.worldinvestorlink.com) has opened information channels from public companies to potential investors. This year World Investor Link will make more than 5 million investor introductions to over 4,600 corporate clients world wide through services including The Annual Reports Service, The Fund Info Service, Vcall (www.vcall.com), Investor Conference (www.investorconference.com), and Informed Investors Forums (www.informedinvestors.com). World Investor Link's array of products and services enables companies to comply with regulation fair-disclosure requirements by providing investors free access to onsite and webcast investor events and company financial reports. Mutual funds and companies get visibility with investors at the point investors are making decisions through World Investor Link's relationships with over 160 of the leading financial media channels including The Wall Street Journal, Barron's and Yahoo!Finance. World Investor Link, Inc., a wholly owned subsidiary of WILink.com plc (WLK on The London Stock Exchange), began operations in Richmond, Va. in 1993.